MedPath
NMPA Approval

Epalrestat Tablets

国药准字H20253176

January 14, 2025

Drug Information

依帕司他片

片剂

50mg

化学药品

January 14, 2025

Company Information

Applicant Company

南京市栖霞区仙林街道纬地路9号江苏生命科技创新园C6栋603室

Manufacturing Company

浙江省宁波市北仑区大榭街道滨海西路85号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

依帕司他片 - NMPA 批准文号 | MedPath